# 敲除小鼠模型市场

> 敲除小鼠模型市场研究报告按应用（肿瘤研究、遗传研究、药物研究、免疫学研究）、按类型（构成性敲除小鼠、条件性敲除小鼠、转基因小鼠）、按主要终端用户（学术机构、生物技术公司、制药公司、合同研究组织）、按技术（CRISPR-Cas9、同源重组、基因靶向）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.32%
- **2024:** $ 2.74 Billion
- **2025:** $ 2.94 Billion
- **2035:** $ 5.97 Billion
- **Key Players:** Jackson Laboratory (US), Charles River Laboratories (US), Taconic Biosciences (US), Horizon Discovery (GB), GenOway (FR), Crown Bioscience (US), InVivo Biosystems (US), The Jackson Laboratory (US)

**Report ID:** MRFR/HC/30879-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/knock-out-mice-model-market-32678

---

## Market Summary

## **Knockout Mice Model Market Overview**

As per MRFR analysis, the Knock Out Mice Model Market Size was estimated at 2.74 (USD Billion) in 2024. The Knock Out Mice Model Market Industry is expected to grow from 2.94 (USD Billion) in 2025 to 5.56 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.32% during the forecast period (2025 - 2034).

### **Key Knockout Mice Model Market Trends Highlighted**

The Global Knockout Mice Model Market is witnessing significant growth due to several key market drivers. Increased investment in biomedical research, driven by the demand for advanced therapeutic solutions, is propelling the use of knockout mice in studies related to genetic disorders, cancer, and cardiovascular diseases. The rise of personalized medicine is also fueling the need for precise animal models that can closely mimic human genetic conditions. Additionally, supportive government initiatives and funding for research and development activities further stimulate market growth.

There are abundant opportunities to be explored in the knockout mice model market, primarily in areas that focus on innovation in genetic engineering technologies. As CRISPR and other gene-editing tools become more accessible, researchers are likely to adopt these advanced techniques to create custom models tailored to specific research needs, thus enhancing the scope of studies conducted. Collaboration between academia and industry can also lead to the development of novel knockout mouse models that address unmet medical needs, expanding their application in drug discovery and toxicology studies.

Recent trends indicate a shift toward the use of high-throughput screening techniques and more sophisticated genetic manipulations that offer researchers greater efficiency and accuracy. The increasing integration of artificial intelligence and machine learning in research, including the analysis of knockout mice data, is also transforming the landscape.

This convergence allows for an enhanced understanding of biological pathways, paving the way for new therapeutic discoveries. As the market evolves, ethical considerations and animal welfare regulations are becoming integral, driving the need for more comprehensive and humane research practices. Overall, the knockout mice model market is positioned for continued expansion, driven by technological advancements, heightened research initiatives, and an ever-growing focus on precision medicine.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

## **Knockout Mice Model Market Drivers**

### **Rising Demand for Customized Mouse Models**

The Global Knockout Mice Model Market Industry is experiencing a significant surge in demand for customized and genetically modified mouse models. This increasing requirement arises from the need for more precise and relevant animal models in biological and biomedical research. Organizations are focused on creating animal models that closely mimic human diseases, which allows for an improved understanding of disease mechanisms and accelerated drug discovery processes.

As researchers seek to develop therapies tailored to specific patient populations, they are turning towards knockout mice models for their ability to elucidate the role of specific genes in diseases. With advances in genetic engineering techniques, including CRISPR and other genome editing technologies, the creation of customized knockout mice has become more efficient and cost-effective.

This shift towards precision medicine and targeted therapies is anticipated to drive substantial growth in the Global Knockout Mice Model Market, as researchers require these models to study complex diseases like cancer, cardiovascular diseases, and neurological disorders.

Furthermore, as regulatory agencies emphasize the need for reliable preclinical data, the reliance on genetically modified mouse models is expected to increase. The capacity of knockout mice to mimic human conditions and respond to treatments in a manner reflective of human biology positions them as invaluable assets in the pharmaceutical and biotechnology sectors. Consequently, the customizability of knockout mice models tailored to specific genetic backgrounds enhances their appeal, ultimately supporting the expansion of the Global Knockout Mice Model Market.

### **Increasing Investment in Pharmaceutical Research and Development**

The rising investments in pharmaceutical research and development are significantly bolstering the Global Knockout Mice Model Market Industry. With a growing focus on innovative drug development and the need for efficient testing methods, pharmaceutical companies are increasingly turning to knockout mice models as a foundational tool in their R processes. These models allow for the evaluation of therapeutic efficacy, safety, and mechanisms of action, leading to more successful clinical outcomes.

The substantial funding being allocated by both public and private sectors for drug discovery further emphasizes the critical role of animal models in translating research into viable therapies. Consequently, this trend is set to propel the growth of the Global Knockout Mice Model Market as organizations seek to meet the demands of modern pharmaceutical research.

### **Advancements in Genetic Engineering Techniques**

Technological advancements in genetic engineering techniques are a primary driver of growth in the Global Knockout Mice Model Market Industry. Innovations such as CRISPR-Cas9 and other genome editing tools have revolutionized the creation of knockout mice, making the process more precise, efficient, and less time-consuming. These advancements facilitate the generation of mouse models that can accurately represent specific genetic alterations, offering valuable insights into various diseases.

The ability to manipulate genes with high specificity enhances the relevance of knockout models in research, prompting pharmaceutical companies and academic institutions to adopt these technologies. As a result, the ongoing evolution of genetic engineering capabilities directly influences the growth trajectory of the Global Knockout Mice Model Market, enabling researchers to explore new therapeutic avenues and enhance preclinical testing protocols.

## **Knockout Mice Model Market Segment Insights**

### **Knockout Mice Model Market Application Insights**

The Application segment within the Global Knockout Mice Model Market is a pivotal aspect that highlights the diverse areas of research leveraging these models. As of 2023, the overall market is valued at 2.39 USD Billion, reflecting the growing reliance on knockout mice for biomedical research. The segment includes key applications such as Oncology Research, Genetic Research, Pharmaceutical Research, and Immunology Research, each playing a crucial role in advancing scientific knowledge and therapeutic developments.

Oncology Research holds the largest share, valued at 0.95 USD Billion in 2023, and is projected to grow to 1.8 USD Billion by 2032, underscoring its significance in cancer research. The extensive use of knockout mice in this area aids in understanding tumor biology and developing targeted therapies.

Genetic Research, valued at 0.65 USD Billion in 2023, is another significant area, expected to reach 1.2 USD Billion by the end of the forecast period. This application is critical for insights into genetic diseases and gene function, making it foundational for the development of gene editing technologies and personalized medicine.

Pharmaceutical Research, at 0.59 USD Billion in 2023, is projected to grow to 1.1 USD Billion by 2032, highlighting its role in drug discovery and efficacy testing, where knockout models help in elucidating drug mechanisms and potential downstream effects. Lastly, Immunology Research, although the smallest segment valued at 0.2 USD Billion in 2023, is expected to double to 0.4 USD Billion by 2032.

This application enables researchers to study immune responses and develop vaccines, making it essential for public health initiatives. The evident dominance of Oncology Research within the Global Knockout Mice Model Market reflects its critical importance in addressing one of the most challenging health issues worldwide, while Genetics and Pharmaceutical Research also play crucial roles in revolutionizing modern medicine.

Various market trends indicate a growing investment in these areas, driven by advancements in technology and a greater focus on personalized treatments. Therefore, the Global Knockout Mice Model Market data reveals a dynamic landscape marked by significant growth opportunities and challenges, particularly in expanding the application of these models to further enhance research capabilities across multiple disciplines.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

### **Knockout Mice Model Market Type Insights**

In 2023, the Global Knockout Mice Model Market was valued at 2.39 billion USD, reflecting a robust market focused on various types of knockout mice, including Constitutive, Conditional, and Transgenic Mice. Constitutive Knockout Mice, which have gene deletions that occur in all cells, often play a critical role in studying gene function across different tissues, aiding biomedical research substantially.

Conditional Knockout Mice provide an advantage by allowing researchers to control when and where genes are inactivated, leading to more targeted studies, which have gained traction due to their precise applications in disease modeling. Transgenic Mice, designed to carry extra genes, significantly contribute to understanding gene expression and function, hence occupying a significant portion of the market share.

These mouse types are increasingly used due to their essential roles in drug development, genetic research, and studying various diseases. The market growth is propelled by advancements in genetic engineering technologies and an increasing focus on personalized medicine, although challenges like ethical concerns and high production costs continue to impact accessibility. As the landscape for research methodologies evolves, the need for innovative knockout models will drive the Global Knockout Mice Model Market revenue further upwards.

### **Knockout Mice Model Market Key End User Insights**

In 2023, the Global Knockout Mice Model Market was valued at approximately 2.39 billion USD and is experiencing significant traction due to its application across various key end users. Academic institutions are crucial players, utilizing knockout mice models extensively for genetic research and educational purposes. Biotechnology companies also contribute notably to the market, focusing on innovative therapies and drug development, which rely heavily on these models to understand gene functions.

Pharmaceutical companies dominate this space, as they leverage knockout mice for preclinical studies to test drug efficacy and safety. Furthermore, contract research organizations play a vital role in offering services that streamline the research process for biotech and pharmaceutical companies. The increasing demand for personalized medicine and advancements in genetic engineering are driving the growth of these end-user segments, contributing to a robust market landscape.

Challenges such as ethical considerations and regulatory hurdles persist, but the opportunities for innovation and research advancement remain promising, positioning the Global Knockout Mice Model Market for continued growth and engagement across key sectors.

### **Knockout Mice Model Market Technology Insights**

The Technology segment of the Global Knockout Mice Model Market reflects substantial growth, with the overall market valued at 2.39 USD Billion in 2023. As science progresses, techniques such as CRISPR-Cas9 have gained prominence due to their efficiency and precision in gene editing, making them crucial for advancing genetic research.

Homologous recombination also plays a significant role, providing established methodologies for targeted gene alteration in mice. Gene targeting remains foundational as it helps create specific mutations for studying various diseases, thus enabling significant discoveries in biomedical research.

Together, these methodologies demonstrate the dynamic landscape of the Global Knockout Mice Model Market, showcasing the integration of innovative technologies that drive research and therapeutic developments. The market, driven by increasing demand for personalized medicine and genetic studies, faces challenges such as ethical considerations and regulatory hurdles, but opportunities in novel applications continue to emerge, fostering robust market growth. The importance of these technologies is underscored by their ability to enhance understanding of genetic functions and promote the development of advanced treatment strategies.

### **Knockout Mice Model Market Regional Insights**

The Global Knockout Mice Model Market revenue is witnessing consistent growth across various regions, with North America taking a significant lead in market valuation. In 2023, North America was valued at 1.05 USD Billion and is projected to reach 2.1 USD Billion by 2032, demonstrating its majority holding in the market. Europe follows as another key player, registering a market value of 0.8 USD Billion in 2023 and advancing to 1.4 USD Billion by 2032, highlighting its important role in research and development.

The APAC region, valued at 0.41 USD Billion in 2023, shows potential for growth, reaching 0.9 USD Billion by 2032, driven by increasing investments in biotechnology.

South America and MEA represent smaller yet developing segments, with valuations of 0.07 USD Billion and 0.06 USD Billion in 2023, respectively, expected to grow modestly to 0.15 USD Billion each by 2032. The market faces challenges such as stringent regulations and high costs, but opportunities arise from improved research capabilities and technological advancements, enhancing overall market growth and Global Knockout Mice Model Market statistics.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

## **Knockout Mice Model Market Key Players and Competitive Insights:**

The competitive landscape of the Global Knockout Mice Model Market is characterized by a diverse array of players, each contributing to the advancement of genetic research and pharmaceutical development through innovative approaches. This market has seen significant growth due to the increasing demand for personalized medicine and the rising prevalence of genetic disorders.

As research institutions and pharmaceutical companies strive to overcome challenges in drug development and understanding complex diseases, the need for precise and reliable animal models becomes paramount. Knockout mice, which are genetically modified to lack specific genes, serve as critical tools in this endeavor. Thus, companies involved in the production and development of knockout mice are continuously enhancing their technologies, methodologies, and service offerings, creating a dynamic competitive environment that drives innovation and collaboration across the industry.

genOway stands out in the Global Knockout Mice Model Market due to its strong focus on customized genetic models and its commitment to high-quality service. The company leverages advanced genetic engineering techniques to develop tailored knockout models that meet specific client requirements, thereby addressing unique research questions. This adaptability gives genOway a competitive advantage, as researchers are increasingly seeking models that closely mimic human diseases for more effective drug testing and therapeutic development.

With a robust portfolio of knockout mice that are effectively validated for various applications, genOway enjoys a solid reputation among academic and biotech organizations. The company's emphasis on customer support, scientific expertise, and reliability further solidifies its market presence, allowing it to build long-term partnerships with clients in need of sophisticated genetic models.

Charles River Laboratories holds a prominent position in the Global Knockout Mice Model Market, recognized for its comprehensive portfolio of research models and in-depth expertise in genetic engineering. The company has established a reputation for delivering high-quality knockout models that accelerate drug discovery and preclinical development.

Charles River Laboratories distinguishes itself through its extensive breeding and production capabilities, ensuring a consistent supply of genetically modified mice that meet stringent quality standards. Furthermore, the company emphasizes innovation through ongoing investment in cutting-edge technology and research collaborations, enabling it to stay at the forefront of genetic research. The combination of a wide-ranging product offering and a focus on advancing genetic models makes Charles River Laboratories a key player in the knockout mice market, catering to diverse needs across the pharmaceutical and academic sectors.

### **Key Companies in the Knockout Mice Model Market Include**

- genOway
- Charles River Laboratories
- Horizon Discovery
- The Jackson Laboratory
- Envigo
- Biocytogen
- Cure Genetics
- Thermo Fisher Scientific
- Crown Bioscience
- Integrative Biology
- Celerion
- OncoOne
- **[Jackson Laboratory](https://www.jax.org/orderform)**
- Taconic Biosciences
- PharmaCyte Biotech

## **Knockout Mice Model Market Industry Developments**

In the Global Knockout Mice Model Market, significant recent developments have been noted, particularly among leading companies like genOway, Charles River Laboratories, and Horizon Discovery. These organizations have been increasingly focusing on expanding their product portfolios and enhancing their technological capabilities to meet growing research demands.

The Jackson Laboratory and Envigo have also made strides in improving the genetic engineering techniques used for creating knockout mice, which contribute to advancements in biomedical research. Additionally, Biocytogen has gained attention for its innovative models catering to specific therapeutic areas.

On the merger and acquisition front, notable transactions have involved key players such as Thermo Fisher Scientific and Crown Bioscience, with activities aimed at consolidating capabilities and expanding market reach.

The financial health of companies involved in this market has been bolstered by a rising demand for genetic disease modeling, significantly impacting overall market growth. This evolution reflects a dynamic landscape where collaboration, technological innovation, and strategic partnerships are paramount for driving the success of knockout mice models in various research applications.

## **Knockout Mice Model Market Segmentation Insights**

### **Knockout Mice Model Market Application Outlook**

- Oncology Research
- Genetic Research
- Pharmaceutical Research
- [Immunology](../../../reports/immunology-market-30261) Research

### **Knockout Mice Model Market Type Outlook**

- Constitutive Knockout Mice
- Conditional Knockout Mice
- Transgenic Mice

### **Knockout Mice Model Market Key End User Outlook**

- Academic Institutions
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organizations

### **Knockout Mice Model Market Technology Outlook**

- CRISPR-Cas9
- Homologous Recombination
- Gene Targeting

### **Knockout Mice Model Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### 协作研究倡议

敲除小鼠模型市场受益于学术机构、制药公司和生物技术公司之间的合作研究倡议。这些合作通常专注于开发新型治疗策略和利用敲除小鼠验证新药靶点。这种合作增强了资源共享和知识交流，可能导致更高效的研究成果。截至2025年，许多利用敲除小鼠研究复杂疾病（包括癌症和神经退行性疾病）的倡议正在进行中。日益增加的联合研究项目可能会推动对敲除小鼠模型的需求，因为它们提供了一个可靠的平台，用于测试假设和验证各个研究领域的发现。

### 基因工程的进展

由于基因工程技术的进步，基因敲除小鼠模型市场正在经历快速增长。CRISPR-Cas9和TALEN等创新技术彻底改变了在小鼠中进行精确基因修改的能力。这种精确性使研究人员能够开发出与人类疾病密切相似的模型，从而增强了临床前研究的相关性。到2025年，基因工程工具市场预计将达到可观的数字，表明强劲的增长轨迹。生成具有特定基因缺失的基因敲除小鼠的能力促进了基因功能和疾病机制的探索，这对药物发现和开发至关重要。因此，随着研究人员寻求利用这些先进技术加速他们的研究，基因敲除小鼠模型的需求可能会增加。

### 个性化医疗需求上升

敲除小鼠模型市场受到个性化医疗需求上升的显著影响。随着医疗保健向量身定制的治疗转变，能够准确代表人类遗传多样性的动物模型的需求变得至关重要。敲除小鼠作为理解疾病遗传基础的重要工具，对于开发个性化疗法至关重要。预计个性化医疗市场在未来几年将以超过10%的年复合增长率（CAGR）增长，反映出对研究和开发的投资不断增加。这一趋势强调了敲除小鼠模型在识别患者特定治疗反应中的重要性，从而推动它们在学术和制药研究环境中的应用。

### 动物研究中的技术创新

敲除小鼠模型市场正受到动物研究方法技术创新的推动。成像技术、数据分析和生物信息学的进步正在增强研究人员有效利用敲除小鼠模型的能力。这些技术允许更详细的表型特征描述和对基因修饰生物学意义的更好理解。到2025年，人工智能和机器学习在研究中的整合预计将进一步简化来自敲除小鼠研究的数据分析。这一研究技术的演变不仅提高了实验的效率，还增加了结果的准确性，从而在生物医学研究的各个领域促进了对敲除小鼠模型的更大依赖。

### 增加对生物医学研究的投资

由于对生物医学研究的投资不断增加，基因敲除小鼠模型市场正处于增长的态势。各国政府和私人机构正在分配大量资金以支持旨在理解遗传疾病和开发新疗法的研究计划。这种财政支持对于创建和维护基因敲除小鼠群体至关重要，这些小鼠对于实验研究是必不可少的。近年来，生物医学研究的资金显著增加，每年投资数十亿美元。这一趋势表明对推动科学知识的持续承诺，这反过来又推动了对基因敲除小鼠模型的需求，因为研究人员寻求探索疾病的遗传基础并测试潜在的治疗方法。

## Future Outlook

敲除小鼠模型市场预计将在2024年至2035年间以7.32%的年均增长率增长，推动因素包括基因研究的进展、个性化医疗的需求增加以及生物技术投资的上升。

**New opportunities:**

- 为研究机构开发定制的基因编辑服务。

到2035年，市场预计将巩固其作为生物医学研究基石的地位。

## Segment Insights

### 按应用：肿瘤研究（最大）与免疫学研究（增长最快）

基因敲除小鼠模型市场展现出多样化的应用分布，其中肿瘤学研究占据了最大的市场份额。该细分市场受到全球癌症发病率上升的推动，促使在肿瘤学研究中进行大量投资，以开发新疗法。紧随其后的是遗传学和制药研究，这些领域也对市场做出了重要贡献，而免疫学研究则作为一个关键领域正在强劲崛起，反映出针对自身免疫性和传染性疾病的治疗方法的显著演变。
此外，基因敲除小鼠模型市场的增长趋势受到基因工程和生物制药技术进步的重大影响。随着研究旨在揭示复杂的生物途径和机制，对创新模型如基因敲除小鼠的需求正在加剧。特别是免疫学研究领域，由于对免疫系统疾病的认识提高和正在进行的临床试验，其地位正在迅速上升，成为该市场中增长最快的领域。

肿瘤研究：主导与免疫学研究：新兴

肿瘤学研究是基因敲除小鼠模型市场的主导领域，其在癌症研究和药物发现过程中的关键作用显而易见。该领域受益于大量的公共和私人资金，以及全球对有效癌症疗法的迫切需求。相比之下，免疫学研究正逐渐成为一个值得关注的领域，利用基因敲除小鼠模型研究免疫反应的基础及疫苗的开发。免疫学的快速发展与针对自身免疫疾病和传染病的研究倡议的增加相一致，促进了市场的蓬勃发展。随着这两个领域的不断进展，它们的相互依赖可能会导致治疗开发中的创新方法，以及对疾病机制的更全面理解。

### 按类型：构成性基因敲除小鼠（最大）与条件性基因敲除小鼠（增长最快）

在基因敲除小鼠模型市场中，各种类型的市场份额分布以构成性敲除小鼠为主导。由于其在遗传研究和疾病建模中的广泛应用，该细分市场占据了最大的份额。相比之下，尽管条件性敲除小鼠目前的市场份额较小，但随着研究人员越来越多地采用先进的靶向基因表达技术，它们正在迅速获得关注。

敲除小鼠：构成性（显性）与条件性（新兴）

构成性基因敲除小鼠在市场中占据主导地位，其特征是完全基因失活，有效地使基因在整个生物体的生命周期内失去活性。这种已建立的类型主要用于需要完全丧失基因功能的研究。与此同时，条件性基因敲除小鼠正在兴起，通过靶向基因编辑提供灵活性，使研究人员能够在特定组织或特定发育阶段激活或失活基因。随着技术的进步，控制基因表达的能力可能会加速这一细分市场的增长，以满足科学界不断变化的需求。

### 按关键最终用户：制药公司（最大）与生物技术公司（增长最快）

敲除小鼠模型市场在各主要终端用户之间展现出多样化的市场份额分布，制药公司因其在药物发现和测试方面的广泛研究与开发活动而占据最大份额。学术机构紧随其后，重度依赖敲除小鼠进行基础研究和教学。合同研究组织（CRO）发挥着至关重要的支持作用，为制药和生物技术公司提供必要的服务，从而显著影响其市场动态。

学术机构（主导）与合同研究组织（新兴）

在基因敲除小鼠模型市场中，学术机构通过利用这些模型进行开创性研究和教育目的而占据主导地位。它们的基础设施和资金支持强大的研究项目，使其成为推动遗传学研究的重要参与者。另一方面，合同研究组织（CRO）代表了一个新兴的细分市场，正变得越来越重要。它们提供临床前和临床开发的外包解决方案，使制药和生物技术公司能够专注于创新。随着药物开发的加速，CRO预计将迅速增长，提供满足客户复杂需求的定制服务。

### 通过技术：CRISPR-Cas9（最大）与同源重组（增长最快）

在基因敲除小鼠模型市场中，CRISPR-Cas9占据了最大的市场份额，反映了其在基因编辑中的高效性和精确性所带来的主导地位。这项技术已成为研究人员和科学家的首选，使得与传统方法相比，敲除模型的生成更加快速和具有成本效益。同时，同源重组虽然市场份额较小，但因其在生成精确的基因修饰方面的关键作用而受到关注，特别是在基因治疗的特定应用中。

技术：CRISPR-Cas9（显性）与同源重组（新兴）

CRISPR-Cas9因其用户友好性和多功能性而成为基因敲除小鼠模型市场的主导技术，迅速改变了研究范式。它允许进行有针对性的修改，且相对低的脱靶效应，使其在学术界和工业界都备受青睐。另一方面，同源重组正在成为特定应用的关键参与者，这些应用需要高精度，例如生成复杂疾病的特定模型。尽管被CRISPR-Cas9所掩盖，但其在专业研究中的相关性确保了它吸引持续的投资和研究兴趣，为潜在增长奠定了基础。

## Regional Market Share Analysis

全球基因敲除小鼠模型市场的收入在各个地区持续增长，其中北美在市场估值中占据了重要领先地位。2023年，北美的市场估值为10.5亿美元，预计到2032年将达到21亿美元，显示出其在市场中的主导地位。欧洲作为另一个关键参与者，2023年的市场价值为8亿美元，预计到2032年将增长至14亿美元，突显其在研究和开发中的重要作用。

亚太地区在2023年的估值为4.1亿美元，显示出增长潜力，预计到2032年将达到9亿美元，受益于生物技术投资的增加。

南美和中东及非洲代表了较小但正在发展的市场细分，2023年的估值分别为0.7亿美元和0.6亿美元，预计到2032年将适度增长至1.5亿美元。市场面临严格的监管和高成本等挑战，但由于研究能力的提升和技术进步，市场增长和全球基因敲除小鼠模型市场统计数据的机会也在增加。

**来源：初步研究、二次研究、MRFR数据库和分析师评审**

## Competitive Benchmarking

全球基因敲除小鼠模型市场的竞争格局由多样化的参与者构成，各自通过创新的方法推动基因研究和制药开发的进步。由于对个性化医疗的需求不断增加以及遗传疾病的发病率上升，该市场经历了显著的增长。

随着研究机构和制药公司努力克服药物开发和理解复杂疾病的挑战，对精确可靠的动物模型的需求变得至关重要。基因敲除小鼠是经过基因改造以缺失特定基因的小鼠，作为这一努力中的关键工具。因此，参与基因敲除小鼠生产和开发的公司不断提升其技术、方法和服务，创造出一个动态的竞争环境，推动行业内的创新与合作。

genOway在全球基因敲除小鼠模型市场中脱颖而出，因其对定制基因模型的强烈关注和对高质量服务的承诺。该公司利用先进的基因工程技术开发符合特定客户需求的定制基因敲除模型，从而解决独特的研究问题。这种适应性使genOway具备了竞争优势，因为研究人员越来越寻求能够更有效地模拟人类疾病的模型，以便进行更有效的药物测试和治疗开发。

凭借一系列有效验证的基因敲除小鼠产品，genOway在学术界和生物技术组织中享有良好的声誉。该公司对客户支持、科学专业知识和可靠性的重视进一步巩固了其市场地位，使其能够与需要复杂基因模型的客户建立长期合作关系。

查尔斯河实验室在全球基因敲除小鼠模型市场中占据重要地位，以其全面的研究模型组合和深入的基因工程专业知识而闻名。该公司已建立起提供高质量基因敲除模型的声誉，能够加速药物发现和临床前开发。

查尔斯河实验室通过其广泛的繁殖和生产能力使自己与众不同，确保持续供应符合严格质量标准的基因改造小鼠。此外，该公司通过持续投资于尖端技术和研究合作，强调创新，使其能够始终处于基因研究的前沿。广泛的产品供应与推动基因模型发展的重点相结合，使查尔斯河实验室成为基因敲除小鼠市场的关键参与者，满足制药和学术领域的多样化需求。

## Recent News & Developments

在全球基因敲除小鼠模型市场中，最近出现了显著的发展，特别是在genOway、查尔斯河实验室和Horizon Discovery等领先公司中。这些组织越来越专注于扩展其产品组合和增强其技术能力，以满足日益增长的研究需求。

杰克逊实验室和Envigo也在改善用于创建基因敲除小鼠的基因工程技术方面取得了进展，这有助于生物医学研究的进步。此外，Biocytogen因其针对特定治疗领域的创新模型而受到关注。

在并购方面，涉及的关键参与者如Thermo Fisher Scientific和Crown Bioscience进行了显著交易，旨在整合能力和扩大市场覆盖范围。

参与该市场的公司的财务健康状况因对遗传疾病建模的需求上升而得到增强，这对整体市场增长产生了重大影响。这一演变反映了一个动态的格局，在这个格局中，合作、技术创新和战略伙伴关系对于推动基因敲除小鼠模型在各种研究应用中的成功至关重要。

## Report Scope

| 2024年市场规模 | 2.744（十亿美元） |
| --- | --- |
| 2025年市场规模 | 2.945（十亿美元） |
| 2035年市场规模 | 5.969（十亿美元） |
| 年复合增长率（CAGR） | 7.32%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 基因编辑技术的进步提高了基因敲除小鼠模型市场的精确性。 |
| 关键市场动态 | 个性化医疗的需求上升推动了基因敲除小鼠模型市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，击败小鼠模型市场的预计市场估值是多少？**
A: 预计到2035年，敲除小鼠模型市场的市场估值将达到59.69亿美元。

**Q: 2024年击倒小鼠模型市场的市场估值是多少？**
A: 2024年，击倒小鼠模型市场的整体市场估值为27.44亿美元。

**Q: 在2025年至2035年的预测期内，击倒小鼠模型市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，基因敲除小鼠模型市场的预期年复合增长率（CAGR）为7.32%。

**Q: 到2035年，哪个应用领域预计将拥有最高的估值？**
A: 肿瘤研究部门预计到2035年将达到182.3亿美元，显示出强劲的增长。

**Q: 市场上主要的基因敲除小鼠模型有哪些类型？**
A: 关键类型包括构成性基因敲除小鼠、条件性基因敲除小鼠和转基因小鼠，预计到2035年，转基因小鼠的市场将达到22.79亿美元。

**Q: 在敲除小鼠模型市场中，主要参与者是谁？**
A: 市场上的主要参与者包括杰克逊实验室、查尔斯河实验室和塔科尼克生物科学公司等。

**Q: 到2035年，制药研究部门的预计估值是多少？**
A: 制药研究部门预计到2035年将达到14.83亿美元，反映其在市场中的重要性。

**Q: 到2035年，预计哪种技术将在基因敲除小鼠模型市场中占主导地位？**
A: 预计CRISPR-Cas9技术将主导市场，预计到2035年估值将达到25亿美元。

**Q: 学术机构作为市场最终用户的预期增长是什么？**
A: 预计到2035年，学术机构的市场规模将达到1845亿美元，表明它们在市场中扮演着重要角色。

**Q: 到2035年，条件性敲除小鼠的市场与其他类型相比如何？**
A: 到2035年，条件性敲除小鼠的市场预计将达到18.45亿美元，显示出与其他类型相当的增长。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/knock-out-mice-model-market-32678*